Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radical Surgery

Active, not recruitingOBSERVATIONAL
Enrollment

740

Participants

Timeline

Start Date

February 4, 2017

Primary Completion Date

October 20, 2023

Study Completion Date

February 29, 2024

Conditions
Gastrointestinal Cancer
Trial Locations (12)

110002

The First Affiliated Hospital of China Medical University, Shenyang

116001

Affiliated Zhongshan Hospital of Dalian University, Dalian

116011

The First Affiliated Hospital of Dalian Medical University, Dalian

121012

The First Affiliated Hospital of Jinzhou Medical University, Jinzhou

130041

The Second Hospital of Jilin University, Changchun

150086

The Second Affiliated Hospital of Harbin Medical University, Harbin

161005

The First Affiliated Hospital of Qiqihar Medical College, Qiqihar

210012

Nanjing First Hospital, Nanjing

225001

Northern Jiangsu People's Hospital, Yangzhou

021008

Hulunbuir People's Hospital, Hailar

030012

Shanxi Provincial People's Hospital, Taiyuan

030032

Shanxi Bethune Hospital, Taiyuan

All Listed Sponsors
collaborator

Second Hospital of Jilin University

OTHER

collaborator

Huazhong University of Science and Technology

OTHER

lead

Qidong Gaitianli Medicines Co., Ltd

INDUSTRY

NCT02975661 - Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radical Surgery | Biotech Hunter | Biotech Hunter